CTRI/2019/03/017887尚未招募1 期
To Evaluate the Safety and Tolerability of HTYR091524 Capsules in Healthy Adult Volunteers: A Randomized Open Label three Arm Clinical Study
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy male or female volunteers.
- •2.Aged between 18-65 years.
- •3.Subjects willing to sign informed consent and follow the study procedure.
- •4.Has not participated in a similar investigation in past 2 weeks.
排除标准
- •1.Subjects with any clinically significant serious cardiovascular, cerebrovascular, respiratory, liver, renal, congenital, psychiatric, metabolic, endocrinal or any other disorder.
- •2.A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the test products
- •3.Alcoholics and smokers
- •4.Pre-existing systemic disease necessitating long-term medications.
- •5.No other drugs were to be taken during the course of the study.
- •6.Pregnant & breast-feeding women.
- •7.Subjects unwilling to provide informed consent or abide by the requirements of the study
研究者
相似试验
招募中
2 期
To Evaluate the Efficacy and Safety of thyroid capsule in the Management of Subclinical Hypothyroidism- An Open Label Clinical Studyâ??CTRI/2019/12/022481The Himalaya Drug Company Ltd
撤回
1 期
Safety and tolerability of the Traditional Chinese Medicine Formulation GOPAC in patients with advanced malignancyAdvanced malignancy (palliative)Cancer - Other cancer typesACTRN12609000652279Sydney South West Area Health Service70
招募中
1 期
The effect of empagliflozin on proteinuriaIRCT20220405054414N1Iran University of Medical Sciences15
已完成
不适用
A Safety and Technical Feasibility Evaluation of the Curvafix® Intramedullary Rodscrew System for Fixation of Pelvic and Acetabular FracturesPelvic ring fractureAcetabular FractureInjuries and Accidents - FracturesMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgeryACTRN12619000860167CurvaFix, Inc.26
进行中（未招募）
不适用
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children with Hemodynamically Significant Congenital Heart Disease.EUCTR2007-002070-61-SEMedImmune LLC800